1208091

AbbVie Inc. — FEI 3010166391

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wyandotte, MI (United States)